A detailed history of Jefferies Financial Group Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 315,048 shares of TXG stock, worth $4.98 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
315,048
Holding current value
$4.98 Million
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.71 - $23.49 $4.95 Million - $7.4 Million
315,048 New
315,048 $7.11 Million
Q3 2023

Nov 14, 2023

BUY
$40.86 - $62.98 $252,759 - $389,594
6,186 New
6,186 $255,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.